- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 4/00 - Peptides having up to 20 amino acids in an undefined or only partially defined sequenceDerivatives thereof
Patent holdings for IPC class C07K 4/00
Total number of patents in this class: 454
10-year publication summary
37
|
24
|
30
|
28
|
19
|
7
|
17
|
12
|
19
|
4
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 20015 |
13 |
Ambrx, Inc. | 183 |
6 |
Emulate, Inc. | 219 |
6 |
Centre National de La Recherche Scientifique | 10476 |
4 |
The United States of America as represented by the Secretary of the Navy | 2767 |
4 |
The Regents of the University of Michigan | 4723 |
4 |
Idemitsu Kosan Co., Ltd. | 4228 |
4 |
President and Fellows of Harvard College | 5993 |
4 |
Duke University | 3078 |
4 |
Aileron Therapeutics, Inc. | 80 |
4 |
The Arizona Board of Regents on Behalf of the University of Arizona | 2172 |
4 |
The University of Chicago | 1417 |
4 |
Genequantum Healthcare (Suzhou) Co., Ltd. | 63 |
4 |
FUJIFILM Corporation | 29489 |
3 |
California Institute of Technology | 3981 |
3 |
The General Hospital Corporation | 4751 |
3 |
Ajinomoto Co., Inc. | 2291 |
3 |
Agency for Science, Technology and Research | 3631 |
3 |
The Board of Trustees of the University of Illinois | 2704 |
3 |
AC Immune S.A. | 264 |
3 |
Other owners | 368 |